The Ministry of Health reminds that antiretroviral treatment in Poland is fully funded under the Government Health Policy Program and available to all people living with HIV - regardless of their health insurance or citizenship.
Polish women eligible for free mammography under the National Health Service expect systemic solutions that will increase the sense of security and quality of breast cancer treatment - especially coordination of oncology care, the ability to get a "second opinion," and access to multi-gene...
On Monday, October 27, the next meeting of the AOTMiT Transparency Council.
A Notice of the Minister of Health dated October 22, 2025 on the list of medicinal products, foodstuffs for special nutritional purposes and medical devices at risk of unavailability on the territory of the Republic of Poland has been published in the Official Journal of the Ministry of...
Poland's drug production is growing - as of 2019, it has increased by 45%, or an average of almost 8% year-on-year. The pharmaceutical sector's long-term contribution to GDP is relatively constant, indicating an industry growth rate comparable to that of the economy as a whole. - However, the...
On Monday, October 20, the next meeting of the Transparency Council.
Polskie Towarzystwo Reumatologiczne pozytywnie ocenia decyzję Ministra Zdrowia o ponownym wprowadzeniu refundacji drugiego leku biopodobnego zawierającego etanercept. Zgodnie z obwieszczeniem z 17 września 2025 r., od 1 października refundowany będzie preparat Nepexto 50 mg dla pacjentów...
On Monday, October 13, the next meeting of the Transparency Council.
On Monday, October 6, the next meeting of the Transparency Council.
Modern therapies in hemophilia mean not only more effective prevention of bleeding, but also a real improvement in patients' quality of life. We talk about the possibilities of modern bleeding prevention and the need for access to various therapies with Professor Wojciech Mlynarski, president of...
On Tuesday, September 30, the next meeting of the Transparency Council.
On Monday, September 29, the next meeting of the Transparency Council.
The Supreme Chamber of Physicians has asked the National Health Fund to provide a list of drugs that most often cause doctors difficulties in determining reimbursement levels. The president of the NRL, Lukasz Jankowski, stresses that the data could be crucial to the work on a modern, automated...
The Polish Society of Rheumatology has issued a position paper on expanding access to innovative treatment for rheumatic diseases in Poland as of October 1, 2025.
Główny Inspektorat Farmaceutyczny dołączył do europejskiej kampanii „Leki to nie słodycze”, która przypomina, że leki dostępne bez recepty powinny być stosowane odpowiedzialnie i zgodnie z zaleceniami.
This year's latest list of reimbursed drugs includes 50 molecules. Nearly half (22) are cancer therapies, including a large group of drugs dedicated to women, the Health Ministry said Monday.
Press conference by Deputy Health Minister Katherine Kacperyczk on the October draft list of reimbursed drugs.
On Monday, September 15, the next meeting of the Transparency Council.
It's all about hemophilia. - With regard to the periodically recurring information in the public space regarding limitations in access to hemophilia treatment, we assure that every patient with hemophilia has access to modern preventive and stabilizing treatment for his disease. The hemophilia...
On Monday, September 8, the next meeting of the Transparency Council.
Simon J. Britsch został powołany na stanowisko prezesa firmy Bayer w Polsce. Obejmuje je równolegle z pełnioną funkcją dyrektora finansowego na region Europy Wschodniej. Jego międzynarodowe doświadczenie oraz dogłębna znajomość firmy Bayer pozwalają mu skutecznie wspierać dalszy rozwój i...
The OJ of the Ministry of Health published a Notice of the Minister of Health dated August 27, 2025 on the list of medicinal products, foodstuffs for special nutritional purposes and medical devices at risk of unavailability on the territory of the Republic of Poland.
More than 26,800 patients participated in commercial clinical trials conducted in Poland in 2024. In four years, Poland has risen from 11th to 9th place in the global ranking of the largest markets for commercial clinical trials. This is good news. The worse news is that for two years we have...
President Karol Nawrocki on August 25, 2025, signed a law amending the regulations on reimbursement of medicines, foodstuffs for special nutritional purposes and medical devices, as well as the Law on Health Care Services. The amendment brings Polish law in line with EU regulations on health...
Osoby przewlekle przyjmujące leki mogą przewozić je przez granice, ale muszą przestrzegać określonych zasad. Obowiązują limity ilościowe, wymóg przewożenia leków w oryginalnych opakowaniach oraz konieczność sprawdzenia przepisów kraju, do którego się udajemy. Rzecznik Praw Pacjenta przypomina...
On Monday, August 25, the next meeting of the Transparency Council.
On Monday, August 18, the next meeting of the Transparency Council.
On Monday, June 11, the next meeting of the Transparency Council.
On Tuesday, August 5, the next meeting of the Transparency Council.
On June 27, 2025, Biogen Inc. (Nasdaq: BIIB) announced new data supporting the clinical efficacy of nusinersen in a diverse population of patients suffering from spinal muscular atrophy.
© 2023 Medexpress. All Rights Reserved
